Hua Medicine (Shanghai) Ltd.
Hua Medicine (Shanghai) Ltd. (HUMDF) Stock Overview
Explore Hua Medicine (Shanghai) Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
430.9M
P/E Ratio
2.82
EPS (TTM)
$0.16
ROE
1.07%
HUMDF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Hua Medicine (Shanghai) Ltd. (HUMDF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 27.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.62.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 2.82 and a market capitalization of 430.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.